Therapeutic effect of folic acid supplementation on type 2 diabetic rat model | ||||
Zagazig University Medical Journal | ||||
Articles in Press, Accepted Manuscript, Available Online from 10 October 2021 | ||||
Document Type: Original Article | ||||
DOI: 10.21608/zumj.2021.89280.2312 | ||||
View on SCiNiTO | ||||
Authors | ||||
Mariam Nasr Michael 1; Maher Nageb Ibrahim2; ebtisam mohamed ebrahim2; nanees fouad elmalkey3 | ||||
1Physiology department, Faculty of Medicine, Zagazig University | ||||
2physiology department ,zagazig university | ||||
3physiology,faculty of medicine,zagazig university,zagazig,Egypt | ||||
Abstract | ||||
Background: type 2 diabetes (DM2)is associated with high risk of microvascular and macrovascular comorbidities. Many micronutrients are involved in combating DM and its complication. Aim of the study: To investigate the effects of Folic acid in albino rats model of DM2. Materials and Methods: Thirty male adult albino rats were divided randomly into 3 groups control, diabetes mellitus (DM2): DM2 was induced by 4 weeks of high fat diet then streptozotocin (25 mg/kg/ i.p, once), and Folic acid-treated DM2 with (5mg/kg b.w) orally for 8 weeks. Serum glucose, Insulin, Lipid profile, CRP were analyzed, HOMA-IR, and plasma atherogenic Index (AIP) were calculated. Results: In Folic acid-treated DM2 group, there was a significant decrease in serum glucose, HOMA-IR, cholesterol, triglyceride, AIP, CRP with significant increase in serum insulin and high density lipoprotein when compared to DM2 group. Conclusion: Use of folic acid was effective in a rat model of DM which is owed to its reducing gluco-metabolic disturbances, antioxidant, anti-inflammatory roles. Key words: Folic acid, Diabetes mellitus type 2. | ||||
Keywords | ||||
Folic acid; Diabetes mellitustype 2; obesity | ||||
Statistics Article View: 131 |
||||